Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Healthcare Realty Trust Incorporated Common Stock (HR) vs Relay Therapeutics Inc. Common Stock (RLAY) Price & Performance

Healthcare Realty Trust Incorporated Common StockTrade
Relay Therapeutics Inc. Common StockTrade

Price performance (Past 24H)

Key statistics

Healthcare Realty Trust Incorporated Common Stock vs Relay Therapeutics Inc. Common Stock — how do they compare? Healthcare Realty Trust Incorporated Common Stock trades at $17 (market cap $5.90B), while Relay Therapeutics Inc. Common Stock trades at $17.07 (market cap $3.81B). The key difference: Healthcare Realty Trust Incorporated Common Stock is the larger of the two by market cap, and Healthcare Realty Trust Incorporated Common Stock pays a 5.57% dividend while Relay Therapeutics Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Healthcare Realty Trust Incorporated Common Stock for 0 Days and Relay Therapeutics Inc. Common Stock for 5 Days on average.

HRRLAY
Market Cap
$5.90B$3.81B
Volume
4,466,6101,706,150
Sector
Real EstateHealth
52-Week High
$21.87$20.75
52-Week Low
$16.34$6.05
Typical Hold Time
0 Days5 Days
Enterprise Value
$10.29B$2.93B
Dividend Yield
5.57%—

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Healthcare Realty Trust Incorporated Common Stock

No Aura AI signal available yet.

Relay Therapeutics Inc. Common Stock

Relay Therapeutics (RLAY) trades at $17.36, down 3.45% today, with technical indicators showing bearish momentum. The company remains in clinical-stage development with negative profitability metrics, including a -2,763.64% net income margin and -$276.48M net loss for 2025. Recent Q2 2026 earnings missed expectations with a loss of $0.41 per share, though the company continues advancing its oncology pipeline with Phase 3 trials planned for 2027.

Despite unanimous analyst buy ratings and a $26.25 consensus price target representing 51% upside, RLAY faces significant execution risk as a pre-revenue biotech. The stock's bearish technical setup and persistent cash burn require careful risk management, though institutional accumulation and AI-driven drug discovery platform provide long-term potential.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

HR
100% Buy0% Sell
Avg holding period · 0 Days
RLAY

No sentiment data available yet.

About Healthcare Realty Trust Incorporated Common Stock

Healthcare Realty Trust Incorporated is a real estate investment trust that owns and manages outpatient medical facilities and on-campus medical office buildings across US, leasing space to physician groups, hospitals, and health systems.

Read more on HR →

About Relay Therapeutics Inc. Common Stock

Relay Therapeutics develops precision medicines for oncology and genetic diseases. Its drug discovery platform studies how protein motion affects drug targets to guide small-molecule medicine design.

Read more on RLAY →